...
首页> 外文期刊>Kaohsiung Journal of Medical Sciences >Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations
【24h】

Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations

机译:实时虚拟超声辅助射频消融治疗在超声检查和高危部位下不起眼的肝细胞癌

获取原文
           

摘要

Radiofrequency ablation (RFA) is an effective and real-time targeting modality for small hepatocellular carcinomas (HCCs). However, mistargeting may occur when the target tumor is confused with cirrhotic nodules or because of the poor conspicuity of the index tumor?under ultrasonography (US). Real-time virtual sonography (RVS) can provide the same?reconstruction computed tomography images as US images. The aim of this study is to?investigate the usefulness of RVS-assisted RFA for HCCs that are inconspicuous or conspicuous under US. A total of 21 patients with 28 HCC tumors—divided into US inconspicuous and high-risk subgroup (3 tumors in 3 patients), US inconspicuous and nonhigh-risk subgroup (5 tumors in 4 patients), US conspicuous and high-risk subgroup (16 tumors in 14 patients), and US conspicuous and nonhigh-risk subgroup (4 tumors in 3 patients)—underwent RVS-assisted RFA between May 2012 and June 2014 in our institution. The mean diameter of the nodules was 2.0?±?1.1?cm. The results showed that the complete ablation rate is 87.5% (7/8) in the US undetectable group and 75% (15/20) in the US detectable group. A comparison between six tumors with incomplete ablation and 22 tumors with complete ablation showed higher alpha-fetoprotein level (mean, 1912?ng/mL vs. 112?ng/mL) and larger tumor size (mean diameter, 26?mm vs. 16?mm) in the incomplete ablation nodules (both p ??0.05). In conclusion, RVS-assisted RFA is useful for tumors that are difficult to detect under conventional US and may also be useful for tumors in high-risk locations because it may prevent complication induced by mistargeting.
机译:射频消融(RFA)是小型肝细胞癌(HCC)的一种有效且实时的靶向治疗方式。但是,当目标肿瘤与肝硬化结节相混淆时,或者由于超声检查下超声检查对肿瘤的显着性差,可能会发生误靶。实时虚拟超声(RVS)可以提供与US图像相同的重建计算机断层扫描图像。这项研究的目的是调查RVS辅助的RFA对于在美国之下不起眼或显眼的HCC的有用性。共有21例患有28例HCC肿瘤的患者-分为US不显眼和高风险亚组(3个患者中的3个肿瘤),US不显眼和非高风险亚组(4个患者中的5个肿瘤),US显眼和高风险亚组( 2012年5月至2014年6月,在我们的机构中​​接受了RVS辅助的RFA,其中14例患者中有16例肿瘤),以及美国明显和非高危亚组(3例患者中有4例肿瘤)。结节的平均直径为2.0±1.0±1.1cm。结果显示,在美国无法检测组中,完全消融率为87.5%(7/8),在美国可检测组中为75%(15/20)。比较6例不完全消融的肿瘤和22例完全消融的肿瘤,发现甲胎蛋白水平更高(平均为1912?ng / mL vs. 112?ng / mL),肿瘤尺寸更大(平均直径为26?mm vs. 16)。不完全消融结节中的Δmm)(均p≤0.05)。总之,RVS辅助的RFA可用于常规US难以检测的肿瘤,也可用于高风险部位的肿瘤,因为它可以防止误靶引起的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号